Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles.

Zhang B, Shen S, Liao Z, Shi W, Wang Y, Zhao J, Hu Y, Yang J, Chen J, Mei H, Hu Y, Pang Z, Jiang X.

Biomaterials. 2014 Apr;35(13):4088-98. doi: 10.1016/j.biomaterials.2014.01.046. Epub 2014 Feb 8.

PMID:
24513320
2.

LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.

Zhang B, Sun X, Mei H, Wang Y, Liao Z, Chen J, Zhang Q, Hu Y, Pang Z, Jiang X.

Biomaterials. 2013 Dec;34(36):9171-82. doi: 10.1016/j.biomaterials.2013.08.039. Epub 2013 Sep 3.

PMID:
24008043
3.

EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma.

Zhang B, Wang H, Liao Z, Wang Y, Hu Y, Yang J, Shen S, Chen J, Mei H, Shi W, Hu Y, Pang Z, Jiang X.

Biomaterials. 2014 Apr;35(13):4133-45. doi: 10.1016/j.biomaterials.2014.01.071. Epub 2014 Feb 14.

PMID:
24529623
4.

PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.

Gu G, Hu Q, Feng X, Gao X, Menglin J, Kang T, Jiang D, Song Q, Chen H, Chen J.

Biomaterials. 2014 Sep;35(28):8215-26. doi: 10.1016/j.biomaterials.2014.06.022. Epub 2014 Jun 25.

PMID:
24974009
5.

The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.

Gu G, Gao X, Hu Q, Kang T, Liu Z, Jiang M, Miao D, Song Q, Yao L, Tu Y, Pang Z, Chen H, Jiang X, Chen J.

Biomaterials. 2013 Jul;34(21):5138-48. doi: 10.1016/j.biomaterials.2013.03.036. Epub 2013 Apr 9.

PMID:
23582684
6.

UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma.

Zhang B, Zhang Y, Liao Z, Jiang T, Zhao J, Tuo Y, She X, Shen S, Chen J, Zhang Q, Jiang X, Hu Y, Pang Z.

Biomaterials. 2015 Jan;36:98-109.

PMID:
25443789
7.

Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.

Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X.

Biomaterials. 2011 Jun;32(18):4293-305. doi: 10.1016/j.biomaterials.2011.02.044. Epub 2011 Mar 21.

PMID:
21427009
8.

F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery.

Hu Q, Gu G, Liu Z, Jiang M, Kang T, Miao D, Tu Y, Pang Z, Song Q, Yao L, Xia H, Chen H, Jiang X, Gao X, Chen J.

Biomaterials. 2013 Jan;34(4):1135-45. doi: 10.1016/j.biomaterials.2012.10.048. Epub 2012 Nov 10.

PMID:
23146434
9.

Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel.

Jiang X, Sha X, Xin H, Xu X, Gu J, Xia W, Chen S, Xie Y, Chen L, Chen Y, Fang X.

Biomaterials. 2013 Apr;34(12):2969-79. doi: 10.1016/j.biomaterials.2012.12.049. Epub 2013 Feb 4.

PMID:
23380351
10.

PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy.

Gu G, Xia H, Hu Q, Liu Z, Jiang M, Kang T, Miao D, Tu Y, Pang Z, Song Q, Yao L, Chen H, Gao X, Chen J.

Biomaterials. 2013 Jan;34(1):196-208. doi: 10.1016/j.biomaterials.2012.09.044. Epub 2012 Oct 12.

PMID:
23069707
11.

Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.

Feng X, Yao J, Gao X, Jing Y, Kang T, Jiang D, Jiang T, Feng J, Zhu Q, Jiang X, Chen J.

ACS Appl Mater Interfaces. 2015 Dec 23;7(50):27885-99. doi: 10.1021/acsami.5b09934. Epub 2015 Dec 14.

PMID:
26619329
12.

Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel.

Hu Q, Gao X, Gu G, Kang T, Tu Y, Liu Z, Song Q, Yao L, Pang Z, Jiang X, Chen H, Chen J.

Biomaterials. 2013 Jul;34(22):5640-50. doi: 10.1016/j.biomaterials.2013.04.025. Epub 2013 Apr 29.

PMID:
23639530
13.

Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.

Kang T, Jiang M, Jiang D, Feng X, Yao J, Song Q, Chen H, Gao X, Chen J.

Mol Pharm. 2015 Aug 3;12(8):2947-61. doi: 10.1021/acs.molpharmaceut.5b00222. Epub 2015 Jul 21.

PMID:
26149889
14.

In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.

Gao H, Zhang S, Yang Z, Cao S, Jiang X, Pang Z.

Int J Pharm. 2014 May 15;466(1-2):8-17. doi: 10.1016/j.ijpharm.2014.03.012. Epub 2014 Mar 5.

PMID:
24607217
15.

CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.

Hu Q, Gao X, Kang T, Feng X, Jiang D, Tu Y, Song Q, Yao L, Jiang X, Chen H, Chen J.

Biomaterials. 2013 Dec;34(37):9496-508. doi: 10.1016/j.biomaterials.2013.09.001. Epub 2013 Sep 17.

PMID:
24054848
16.

Co-administration of dual-targeting nanoparticles with penetration enhancement peptide for antiglioblastoma therapy.

Miao D, Jiang M, Liu Z, Gu G, Hu Q, Kang T, Song Q, Yao L, Li W, Gao X, Sun M, Chen J.

Mol Pharm. 2014 Jan 6;11(1):90-101. doi: 10.1021/mp400189j. Epub 2013 Dec 2.

PMID:
24295590
17.

Glioma homing peptide-modified PEG-PCL nanoparticles for enhanced anti-glioma therapy.

Chi Y, Zhu S, Wang C, Zhou L, Zhang L, Li Z, Dai Y.

J Drug Target. 2016;24(3):224-32. doi: 10.3109/1061186X.2015.1070854. Epub 2015 Jul 29.

PMID:
26219518
18.

Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.

Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H.

Biomaterials. 2011 Nov;32(31):8010-20. doi: 10.1016/j.biomaterials.2011.07.004. Epub 2011 Jul 23.

PMID:
21788069
19.

Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.

Xin H, Sha X, Jiang X, Zhang W, Chen L, Fang X.

Biomaterials. 2012 Nov;33(32):8167-76. doi: 10.1016/j.biomaterials.2012.07.046. Epub 2012 Aug 11.

PMID:
22889488
20.

iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas.

Kang T, Gao X, Hu Q, Jiang D, Feng X, Zhang X, Song Q, Yao L, Huang M, Jiang X, Pang Z, Chen H, Chen J.

Biomaterials. 2014 May;35(14):4319-32. doi: 10.1016/j.biomaterials.2014.01.082. Epub 2014 Feb 22.

PMID:
24565520

Supplemental Content

Support Center